Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression
This report summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine in treati...
Main Author: | |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Rockville, MD
Agency for Healthcare Research and Quality
2007, [2007]
|
Series: | Comparative effectiveness review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This report summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine in treating patients with MDD, dysthymia, and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia, or neurovegetative symptoms |
---|---|
Item Description: | Title from PDF title page (viewed June 15, 2011). - "Contract No. 290-02-0016.". - "January 2007." |
Physical Description: | 1 online resource |